SEC Comment Letter 0000000000-24-008851 to Autonomix Medical, Inc. (AMIX)

Autonomix Medical, Inc.
Date: Aug. 2, 2024 · CIK: 0001617867 · Accession: 0000000000-24-008851

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

August 2, 2024

Author

Brad Hauser

Form

UPLOAD

Company

Autonomix Medical, Inc.

Letter

August 2, 2024 Brad Hauser Chief Executive Officer and President Autonomix Medical, Inc. 21 Waterway Avenue Suite 300 The Woodlands, Texas 77380 Re:Autonomix Medical, Inc. Drafted Registration Statement on Form S-1 Submitted July 26, 2024 CIK No. 0001617867 Dear Brad Hauser: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Robert Augustin at 202-551-8483 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services

Show Raw Text

August 2, 2024
Brad Hauser
Chief Executive Officer and President
Autonomix Medical, Inc.
21 Waterway Avenue
Suite 300
The Woodlands, Texas 77380
Re:Autonomix Medical, Inc.
Drafted Registration Statement on Form S-1
Submitted July 26, 2024
CIK No. 0001617867
Dear Brad Hauser:
            This is to advise you that we do not intend to review your registration statement.
            We request that you publicly file your registration statement no later than 48 hours prior to
the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
            Please contact Robert Augustin at 202-551-8483 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services

SecProbe.io